Abstract
Genetic Engineering & Biotechnology NewsVol. 43, No. 4 DepartmentsThe Next Generation of Drugs Will Be Enhanced by Machine LearningExperts from Charles River and Valo Health describe how artificial intelligence will change the drug discovery landscapeGrant Wishart and Guido LanzaGrant WishartGrant Wishart, PhD, is senior director, small molecule drug discovery and Logica lead at Charles River Laboratories. Website: www.criver.com. Guido Lanza is vice president of integrated research and Logica general manager at Valo Health. Website: www.valohealth.com.Search for more papers by this author and Guido LanzaGrant Wishart, PhD, is senior director, small molecule drug discovery and Logica lead at Charles River Laboratories. Website: www.criver.com. Guido Lanza is vice president of integrated research and Logica general manager at Valo Health. Website: www.valohealth.com.Search for more papers by this authorPublished Online:10 Apr 2023https://doi.org/10.1089/gen.43.04.06AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 4Apr 2023 Information© 2023 by GEN PublishingTo cite this article:Grant Wishart and Guido Lanza.The Next Generation of Drugs Will Be Enhanced by Machine Learning.Genetic Engineering & Biotechnology News.Apr 2023.16-17, 19.http://doi.org/10.1089/gen.43.04.06Published in Volume: 43 Issue 4: April 10, 2023PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
